Detailed Narrative
Senior Housing Demand and Supply Dynamics
Ventas is strategically positioned to capitalize on the accelerating demand in senior housing, driven by the aging baby boomer population. The over-80 population is projected to grow 28% in the next 5 years and double in two decades. Concurrently, new senior housing supply remains constrained, with only about 2,500 new units started in Q4 2025, while over 2 million people are expected to turn 80 in 2026. This favorable supply-demand imbalance is a key driver for Ventas's growth outlook.
Ventas OI Platform and Operational Excellence
The proprietary Ventas Operational Insights (OI) platform is a core competitive advantage, enabling the company to drive outperformance across its SHOP portfolio. The platform supports 43 operators, facilitating data analytics, dynamic pricing, sales execution, and benchmarking. In 2025, Ventas deepened collaboration with operators through site visits, summits, and active asset management, leading to improved competitive positioning and strong financial results. The company plans to further expand its senior housing team and enhance interdisciplinary support for its network of high-performing operators.
Strategic Capital Allocation and Investment Activity
Ventas's primary capital allocation priority is U.S. senior housing, with $2.5 billion of acquisitions closed in FY25 and $800 million already closed year-to-date in FY26. These investments are focused on high-quality assets in favorable markets, enhancing the overall SHOP portfolio and enterprise growth rate. The company maintains a robust pipeline of $35 billion in U.S. senior housing opportunities, with a significant portion sourced off-market or through existing operator relationships, allowing for attractive risk-adjusted returns.
Brookdale Transitions and Long-Term Potential
The 45 former Brookdale communities transitioned to SHOP are now fully converted and operated by 5 experienced partners. Capital refresh projects are underway, with most expected to be completed before the key selling season. While modest NOI growth is anticipated in 2026, management remains confident in the long-term opportunity to double NOI across this group of communities, leveraging their large scale and strong market positions.
Outpatient Medical and Research (OMAR) Performance
The OMAR business delivered nearly 4% same-store cash NOI growth in Q4 2025, with outpatient medical leading at 4.5% growth and achieving almost 91% occupancy. The in-house property management teams have consistently delivered strong tenant satisfaction and over 85% TTM retention. The research portfolio, representing 8% of total NOI, grew 30 basis points, supported by university tenants, with overall OMAR same-store NOI guidance set at 2.5% for FY26.
Financial Strength and Leverage Management
Ventas demonstrated strong access to capital, raising over $7 billion since the start of 2025, including $4 billion in debt and $3.2 billion in equity. This capital activity, combined with strong organic growth, improved leverage to 5.2x in Q4 2025, the best since 2012. Pro forma for $12 billion of unsettled equity, leverage is approaching 5x, and the company expects continued deleveraging in 2026.